Cesca Therapeutics - THMO Net earnings per share for the last 12 months

Public company logo of ThermoGenesis Holdings, Inc. (THMO)

ThermoGenesis generates revenue by supplying cell freezing and processing systems to biobanks. High B2B customer loyalty is secured through proprietary cartridges and strict FDA oversight. The PXP technology stack, featuring AI analysis, creates a closed-loop research cycle. Historical EPS YoY TTM dynamics demonstrate the resilience of fundamental indicators, with the metric remaining around 67.70.

ThermoGenesis Holdings - THMO Earnings per share for the last twelve months (period 02/11/2024 - 02/20/2024)

ThermoGenesis Holdings Inc. - analytical breakdowns and key metrics (THMO)

- market price and analyst price targets:
Market Chart thermogenesis.com|THMO - Analyst Consensus Forecast
- issuer market value details:
Market Valuation ThermoGenesis Holdings, Inc.|THMO - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share ThermoGenesis|THMO - Company Book Value|Market Cap to Net Assets Ratio thermogenesis.com|THMO - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital ThermoGenesis|THMO - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Cesca Therapeutics|THMO - Company Aggregate Debts|Debts to Net Assets ThermoGenesis Holdings, Inc.|THMO - Company Long-Term Debts|Company Current Liabilities ThermoGenesis|Quick Ratio thermogenesis.com
- financial results and valuation multiples details:
THMO - Company Net Income|Expected Profit ThermoGenesis|THMO - Price to Earnings Ratio|Future Price to Earnings Multiple ThermoGenesis Holdings, Inc.|THMO - PEG Multiple|Company Value to EBITDA ThermoGenesis Holdings, Inc.|THMO - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year ThermoGenesis|THMO - Net earnings per share for the last 12 months|Quarterly EPS earnings growth thermogenesis.com|THMO - Earnings growth in current year|Consensus forecast of earnings per share growth for next year ThermoGenesis
- revenue and sales details:
THMO - Company Revenue|Company Expected Revenue thermogenesis.com|THMO - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple ThermoGenesis Holdings, Inc.
Fundamental company valuation:THMO (thermogenesis.com)
Core merchandise of thermogenesis.com

The monetization potential of ThermoGenesis (THMO) software determines the long-term value of the business. The trend in the annual percentage change of EPS TTM captures the difference in net income per share over the last 12 months relative to the previous year, excluding seasonal distortions. Current fluctuations on the chart reflect management's struggle with a liquidity shortage. High peaks of the indicator here signal a risk of overpayment. Investment attractiveness remains uncertain until cash flows stabilize.

Competitor analysis for ThermoGenesis

Net earnings per share for the last four quarters abbott.com ABT|TMO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months GE HealthCare Technologies Inc.|Net earnings per share for the last 12 months MTD|WAT: Earnings per share for the trailing year|Earnings per share for the last twelve months Bio-Techne Corporation (TECH)|Net earnings per share for the last 12 months bruker.com BRKR|Net earnings per share (EPS TTM) AZTA (Azenta)|Varex Imaging Corp (VREX) - Net earnings per one share for the last twelve months|Semler Scientific Corp - Net earnings per share (EPS TTM)|BFLY (Butterfly Corp) - Earnings per share for the last 12 months|MLAB: Net earnings per share (EPS TTM)|QSI - Net earnings per share for the last four quarters|NNOX (Nano-X) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Quanterix Corp. (QTRX)|Net earnings per share (EPS TTM) MASS|Net earnings per share (EPS TTM) capsovision.com (CV)|Earnings per share for the last twelve months MaxCyte, Inc. MXCT|Rapid Micro Biosystems Inc. - Earnings per share for the last twelve months|SEER: Net earnings per share for the last 12 months|Earnings per share for the trailing year HYPR (Hyperfine Inc)|FONR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Daxor (DXR)|Earnings per share for the last twelve months Spectral AI, Inc.|VIVS - Net earnings per share for the trailing year|Net earnings per share for the last 12 months ACON (Aclarion, Inc.)|Net earnings per share (EPS TTM) akoyabio.com (AKYA)|Net earnings per share (EPS TTM) TLIS (Talis Biomedical Corporation)|Net earnings per share for the last four quarters T2 Biosystems Inc (TTOO)